Title : Current and emerging therapies for advanced biliary tract cancers.

Pub. Date : 2021 Nov

PMID : 34626563






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ivosidenib, an IDH1 inhibitor, showed improved progression-free survival versus placebo in second-line treatment in the phase 3 ClarIDHy trial. ivosidenib isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens